BU, melphalan and thiotepa as a preparative regimen for auto-transplantation in Hodgkin’s disease

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2012-02, Vol.47 (2), p.311-312
Hauptverfasser:	Ganguly, S, Jain, V, Divine, C, Aljitawi, O, Abhyankar, S, McGuirk, J
Format:	Artikel
Sprache:	eng
Schlagworte:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Antimitotic agents Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Bone marrow Bone marrow, stem cells transplantation. Graft versus host reaction Busulfan - administration & dosage Busulfan - therapeutic use Care and treatment Cell Biology Dosage and administration Hematologic and hematopoietic diseases Hematology Hematopoietic Stem Cell Transplantation - methods Hodgkin Disease - drug therapy Hodgkin Disease - surgery Hodgkin's disease Humans Internal Medicine letter-to-the-editor Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Medical sciences Medicine Medicine & Public Health Melphalan Melphalan - administration & dosage Public Health Risk Factors Stem cell transplantation Stem Cells Thiotepa - administration & dosage Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Transplantation, Autologous Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!